REGENXBIO Inc.
RGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $59 | $80 | $130 | $58 |
| Short-Term Investments | $215 | $244 | $138 | $177 |
| Receivables | $26 | $21 | $19 | $22 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $31 | $29 | $26 | $22 |
| Total Curr. Assets | $332 | $374 | $313 | $278 |
| Property Plant & Equip (Net) | $156 | $161 | $167 | $171 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $33 | $40 | $5 | $10 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $5 | $6 | $7 |
| Total NC Assets | $193 | $207 | $178 | $188 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $525 | $581 | $491 | $466 |
| Liabilities | – | – | – | – |
| Payables | $22 | $22 | $19 | $23 |
| Short-Term Debt | $51 | $8 | $8 | $8 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $13 | $14 | $14 | $0 |
| Other Curr. Liab. | $38 | $76 | $66 | $72 |
| Total Curr. Liab. | $125 | $120 | $107 | $103 |
| LT Debt | $217 | $70 | $72 | $74 |
| Deferred Rev, NC | $21 | $24 | $26 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $154 | $12 | $29 |
| Total NC Liab. | $239 | $248 | $110 | $103 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $67 | $78 | $80 | $82 |
| Total Liabilities | $364 | $367 | $217 | $206 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,059 | -$997 | -$926 | -$932 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $1,221 | $1,211 | $1,201 | $1,193 |
| Total Equity | $161 | $214 | $274 | $260 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $525 | $581 | $491 | $466 |
| Net Debt | $209 | -$2 | -$50 | $25 |